دوره 12، شماره 3 - ( 1-1393 )                   جلد 12 شماره 3 صفحات 228-227 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Júnior J E, Oliveira L G, Fernandes Silva M O, Araujo Júnior E, Camano L. Serum activin A levels and tubal ectopic pregnancy. IJRM. 2014; 12 (3) :227-228
URL: http://ijrm.ssu.ac.ir/article-1-517-fa.html
Serum activin A levels and tubal ectopic pregnancy. International Journal of Reproductive BioMedicine. 1393; 12 (3) :228-227

URL: http://ijrm.ssu.ac.ir/article-1-517-fa.html


چکیده:   (1453 مشاهده)
Ectopic pregnancy (EP) is the most important cause of maternal death in the first trimester accounting for 9 - 13% of all pregnancy-related deaths (1). Despite the use of transvaginal sonography and high sensitive quantitative beta-hCG assays for diagnosis, nearly 40-50% of all EPs may be initially misdiagnosed (2). Therefore, several biomarkers have been investigated for early diagnosis of EP. Activin A, a dimeric glycoprotein belonging to the TGF-β superfamily, has been highlighted among these “new biomarkers” (3). Florio et al reported that serum activin A levels can be markedly lower in women with tubal EP than those levels found either during normal intrauterine pregnancy or spontaneous miscarriage (4). The authors showed that a cut-off value of 0.37 ng/mL have 100% and 99.6% of sensitivity and specificity, respectively for predicting EP. Conversely, Kirk et al demonstrated in another elegant study that activin A has much lower sensitivity and specificity when used as a single biomarker for the diagnosis of EP (5). Bearing on these considerations, it is clear that this subject still needs to be carefully evaluated and it prompted us to develop this project where we compared serum activin A levels in women at first trimester of normal pregnancy to women with tubal EP. The study group was comprised of 5 women with EP. The diagnosis criteria was based on visualization of an adnexial mass by transvaginal scan associated with positive test for β-hCG in women with a suspected EP (amenorrhea, bleeding and pain). For this study were included only those cases in which the gestational age was established between 5-6 weeks gestational age. In all patients the mass was confirmed to be a tubal EP without signs of rupture by pathologist analysis. The control group was comprised of 10 women with normal intrauterine pregnancy at 5-6 weeks gestational age confirmed by transvaginal scan (evaluated by gestational sac measurements and/or crown-rump length). This work has been approved by the Ethics Committee of The Federal University of São Paulo (UNIFESP). Informed consent was obtained from all participants before the blood samples were collected. All blood samples of patients with EP were collected before surgery by peripheral venous puncture and immediately centrifuged at 1000g for 10 minutes; the supernants were stored at -80oC until processing. For the determination of serum activin A levels a commercially available assay for ELISA was used (activin A- Catalog number: Dy338; R&D systems, Inc. Minneapolis, USA). All activin A measurements and analysis were performed in duplicate at the same time. The limit of detection of the kit was less than 0.133 ng/mL. Data were presented as mean and standard deviation. The statistical analysis was performed using Prism software (version 4.02, Graph Pad Software Inc., San Diego, CA). The two groups were compared using Mann-Whitney U test and results were considered significant when p<0.05. The mean gestational age was 5.2±0.14 for the EP group and 5.2±0.19 for the normal intrauterine pregnancy group. The mean of activin A serum levels was 0.26±0.714 ng/mL and 0.37±161.4 ng/mL for women with EP and for women with normal pregnancy, respectively (p=0.206). The Figure 1 depicts all cases studied.
نوع مطالعه: Original Article |

فهرست منابع
1. Nederlof KP, Lawson HW, Saftlas AF, Atrash HK, Finch EI. Ectopic pregnancy surveillance, United States, 1970-1987. MMWR CDC Surveil Summ 1990; 39: 9-17.
2. Abbott J, Emmans LS, Lowenstein SR. Ectopic pregnancy: ten common pitfalls in diagnosis. Am J Emerg Med 1990; 8: 515-522. [DOI:10.1016/0735-6757(90)90154-R]
3. Luisi S, Florio P, Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 2001; 145: 225-236. [DOI:10.1530/eje.0.1450225]
4. Florio P, Severi FM, Bocchi C, Luisi S, Mazzini M, Danero S, et al. Single serum activin a testing to predict ectopic pregnancy. J Clin Endocrinol Metab 2007; 92: 1748-1753. [DOI:10.1210/jc.2006-2188]
5. Kirk E, Papageorghiou AT, Van Calster B, Condous G, Cowans N, Van Huffel S, et al. The use of serum inhibin A and activin A levels in predicting the outcome of pregnancies of unknown location. Hum Reprod 2009; 24: 2451-2456. [DOI:10.1093/humrep/dep066]
6. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997; 138: 3976-3986. [DOI:10.1210/endo.138.9.5403]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به International Journal of Reproductive BioMedicine می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2022 CC BY-NC 4.0 | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb